{"id":"W2063853379","doi":"10.1038/leu.2011.34","title":"A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response","year":2011,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Imatinib; Mitoxantrone; Myeloid leukemia; Internal medicine; Cytarabine; Imatinib mesylate; Etoposide; Oncology; Refractory (planetary science); Gastroenterology; Pharmacology; Chemotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001502938,0.001582978,0.003140114,0.0006367714,0.0004545247,0.001193877,0.001177227,0.001324776,0.003346286],"category_scores_gemma":[0.0007385503,0.0006631242,0.001611903,0.0006093813,0.001433475,0.000971971,0.000379269,0.004172956,0.0009046144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009383127,"about_ca_system_score_gemma":0.001304884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009595714,"about_ca_topic_score_gemma":0.00304949,"domain_scores_codex":[0.9995378,0.0001792152,0.00002254043,0.00009431934,0.00003770203,0.000128484],"domain_scores_gemma":[0.9994327,0.00009665037,0.00009187907,0.0000779094,0.00002293072,0.0002779468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7598634,0.09118612,0.005289775,0.0007520172,0.001833856,0.0002956123,0.0002645103,0.003685911,0.05701065,0.0004779852,0.002670889,0.07666927],"study_design_scores_gemma":[0.4871544,0.4915805,0.01126978,0.00003563774,0.0008144551,0.000259093,0.00007643473,0.001132466,0.005547601,0.0001930069,0.001887284,0.00004930227],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951454,0.001617294,0.0003047367,0.0003056182,0.000118391,0.001094683,0.0004887434,0.00005399562,0.0008710501],"genre_scores_gemma":[0.9925736,0.00161221,0.001003484,0.0004469429,0.0001301388,0.001183375,0.00125538,0.00003142047,0.001763376],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003346286,"threshold_uncertainty_score":0.01119447,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03889073183035269,"score_gpt":0.293776129030658,"score_spread":0.2548853972003053,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}